Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rogaine Extra Strength for Men data support more hair regrowth than original formula.

This article was originally published in The Tan Sheet

Executive Summary

ROGAINE EXTRA STRENGTH "FASTER" HAIR REGROWTH CLAIM NEEDS FURTHER DATA before it can be included in proposed labeling for the baldness treatment, FDA's Nonprescription Drugs and Dermatologic & Ophthalmic Drugs Advisory Committees recommended at a July 16 joint meeting in Bethesda, Md. The group agreed that, because onset of action for the 5% minoxidil solution was not a primary endpoint of sponsor Pharmacia & Upjohn's studies, the claims "Provides more hair regrowth" and "Provides regrowth sooner" are unsubstantiated and should not appear in labeling.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087332

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel